Developing vaccines and sending doctors overseas: How Cuba maintained a low death rate

Developing vaccines and sending doctors overseas: How Cuba maintained a low death rate

Cartoon drawing of people wearing facemasks

Shutterstock

Since last year, approximately 440 Cubans have died from COVID-19, giving Cuba one of the lowest death rates per capita in the world.

Cuba is also developing five COVID-19 vaccines, including two which have entered stage 3 trials. Cuba has heavily invested in its medical and pharmaceutical system for decades, in part because of the six-decade U.S. embargo that has made it harder for Cuba to import equipment and raw materials from other countries.

That investment, coupled with the country’s free, universal healthcare system, has helped Cuba keep the virus under control and quickly develop vaccines against it, says Dr. Rolando Pérez Rodríguez, the director of science and innovation at BioCubaFarma, which oversees Cuba’s medicine development. “We have long experience with these kinds of technologies,” he says.

We also speak with Reed Lindsay, journalist and founder of the independent, Cuba-focused media organization Belly of the Beast, who says U.S. sanctions on Cuba continue to cripple the country. “Cuba is going through an unbelievable economic crisis, and the sanctions have been absolutely devastating,” says Lindsay.

This article is republished from Democracy Now under a Creative Commons license. Read the original article.

You May Also Like:

*****
Back To Front Page